Thinly traded nano cap Lipocine (LPCN) is up 6% premarket, albeit on only 200 shares, in response to the results from a phlebotomy study assessing the pote.
from "phlebotomist" - Google News http://bit.ly/2SsrQVJ
Thinly traded nano cap Lipocine (LPCN) is up 6% premarket, albeit on only 200 shares, in response to the results from a phlebotomy study assessing the pote.
No comments:
Post a Comment